GSK's unusual Jemperli expansion plan wins FDA panel backing — Trials cue up new use for Roche's eye disease drug Vabysmo —AstraZeneca CEO Pascal Soriot aims for 15 new drug launches by 2030-- See more on our front page news http://bit.ly/w28kSd #gsk #fda #vabysmo #clinicaltrials #roche #astrazeneca #druglaunches #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#gsk #FdA #vabysmo #clinicaltrials #roche #astrazeneca #druglaunches #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023 — Astellas taps new CEO —Biogen and Sage get FDA priority review of depression med zuranolone -- See more on our front page news http://bit.ly/w28kSd #sanofi #earnings #druglaunches #astellas #ceos #biogen #sagetherapeutics #fda #depression #postpartumdepression #priorityreview #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma
#Sanofi #earnings #druglaunches #astellas #ceos #biogen #sagetherapeutics #FdA #depression #postpartumdepression #priorityreview #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma